Study raises concerns over Servier, Amgen heart drug
August 31, 2014 at 10:30 AM EDT
BARCELONA, Aug 31 (Reuters) - A major clinical study has raised concerns about a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. group Amgen last year.
